A randomized, double-blind, placebo-controlled Phase 2 trial of evaluating safety and efficacy of different doses and ratios of Cannabis Oil to improve uncontrolled chronic pain in cancer and non-cancer patients

Trial Profile

A randomized, double-blind, placebo-controlled Phase 2 trial of evaluating safety and efficacy of different doses and ratios of Cannabis Oil to improve uncontrolled chronic pain in cancer and non-cancer patients

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 01 Feb 2018

At a glance

  • Drugs Marijuana (Primary)
  • Indications Pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Feb 2018 New trial record
    • 29 Jan 2018 According to a Tetra Bio-Pharma media release, this trial has been approved by Health Canada. This trial will be conducted with Montreal-based Sante Cannabis, Quebecs first medical clinic and resource centre specializing in cannabis and cannabinoids for medical purposes.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top